Another batch of Chinese medicine tablets were exposed as unqualified, the industry consolidation intensified

Recently, the State Drug Administration issued on the website "on 20 batches of drugs do not meet the requirements of the notice" (hereinafter referred to as "notice"), by the Guangxi Zhuang Autonomous Region Food and Drug Inspection Institute and other 7 drug inspection agencies, marked as Jilin Province Tonghua Boxiang Pharmaceutical Co., Ltd. and other 10 pharmaceutical production enterprises produced 20 batches of drugs do not meet the requirements.
it is worth noting that the author combed found that in these 10 pharmaceutical production enterprises produced 20 batches of non-compliant drugs, involving a large number of Chinese medicine tablets including Hongjingtian, Sichuan Wu, former Hu and so on.
in these unqualified Chinese medicine tablets, non-compliance with the provisions of the project mainly involved in the status, identification and so on.
At present, the drug regulatory department has asked relevant enterprises and units to take risk control measures such as suspension of sales and use and recall, to investigate the causes of non-compliance and to carry out effective rectification.
same time, the State Drug Administration also requires the relevant provincial drug regulatory departments to organize investigations into illegal acts committed by the above-mentioned enterprises and units in the production and sale of counterfeit and inferior drugs in accordance with the Drug Administration Law, and to publicly investigate and punish the results in accordance with the provisions.
In fact, the chinese medicine tablet market is very large, the industry is expected to market close to 400 billion yuan, but the quality of Chinese medicine drink tablets uneven problem in recent years is also very prominent, repeatedly exposed as unqualified.
to break the bottleneck of development, in recent years, the relevant departments of the Chinese medicine tablet industry supervision began to upgrade.
, for example, the 2020 edition of the Pharmacopoeia has new regulations for the Chinese medicine tablet industry.
the Chinese medicine growers, Chinese medicine raw materials collection enterprises, Chinese medicine processing and circulation enterprises and other links have put forward strict management requirements to ensure the quality of Chinese medicine tablets.
industry believes that this provision will undoubtedly raise the quality standards of Chinese medicine tablets to a higher level.
In addition, in February this year, the State Drug Administration also issued the "Special Work Programme for the Treatment of Chinese Medicine Tablets", from March 2020 to September 2021, the country carried out a special rectification of Chinese medicine tablets, the focus of inspection includes illegal production and operation of Chinese medicine tablets, the use of unqualified Chinese medicine tablets, Chinese medicine tablets, as well as the operation of the use of units from illegal channels to buy Chinese medicine tablets.
at least 13 provinces, including Beijing, Shanxi, Guangxi and Ningxia, have carried out special corrective actions under the current national policy.
, from July 2020 to June 2021, the company will move from self-examination to centralized inspection.
to carry out self-examination and self-correction, active reporting, active shutdown and rectification of light treatment;
Fact, the quality of Chinese medicine tablets as the focus of the industry and beyond, can affect the direction of the Chinese herbal medicine market an important factor, the promulgation of relevant policies will undoubtedly have an impact on the entire Chinese medicine market.
understood that, with February 2020, China has carried out a number of Chinese medicine drink tablets special rectification, the industry has been generally believed that the Chinese medicine tablets market or face an industry reshuffle.
In general, with the national attention to the treatment of Chinese medicine tablets, as well as the local government agencies have issued clear measures, Chinese medicine drink tablets market is carrying out a major change, although the reform with the consolidation of the growing, a large number of enterprises are doomed to be eliminated, but its results will undoubtedly accelerate the Chinese medicine tablets market to qualified and standardized, so that the entire field of Chinese medicine presents standardization, standardized production and management, thereby promoting the standardization of industry management development.